BRIEF PORTRAIT

We, Pharma Aldenhoven GmbH & Co. KG, were founded in June 1997 and belong to the Maxim Group.

Our site in Aldenhoven provides us with 8,835 square metres of modern production facilities and a high-bay warehouse with storage capacity for around 5,000 pallets.

As a pharmaceutical company, we specialise in the manufacture of over-the-counter pharmaceuticals (OTC products). We also produce an extensive range of various dietary supplements, medicinal products and medicinal cosmetics for our customers.

All of our products are subjected to strict quality controls and therefore meet the EU GMP guideline for “good manufacturing practice for pharmaceuticals”. Various recognised certifications confirm that we meet the strict requirements for manufacturing pharmaceuticals.

Guiding Principles

Our highly qualified employees across all divisions of the company are obliged to adopt the processes which apply in their areas of responsibility and to continuously scrutinise them for quality. The key benchmarks for us include implementing the highest hygiene standards, an environmentally responsible approach to resources, respecting the ethical standards and values of our society, complying with statutory specifications without compromise, and guaranteeing occupational health and safety. We are also a fair employer: safeguarding jobs and good working conditions are very important to us.

We value having an open dialogue with our customers in a spirit of partnership. We aim to offer a customised solution to meet every single individual requirement. It goes without saying that our products are high-quality and safe, and both of these aspects are subject to a process of continuous improvement. At the same time, we have a distinct awareness of costs, which includes both a high level of economic efficiency and investing large parts of our profits back into quality assurance.

Certification

We have the manufacturing licence in accordance with Section 13 of the German Medicines Act for manufacturing liquid and semi-solid dosage forms. For these manufacturing processes, we have multiple certifications in accordance with

GMP (Good Manufactoring Practice)

DIN EN ISO 9001:2008

DIN EN ISO 13485:2012+AC:2012

IFS Version 6, unannounced (International Food Standard)

Energy Management System DIN EN ISO 50001:2011

 

Contacts

Individual service with us starts with a personal conversation. If you have a question about our manufacturing processes or want to market your own brand and want to implement your own ideas together with us, talk to our specialists.

Tel: +49 (0) 2464 589-0
Fax: +49 (0) 2464 589-49

E-mail: info@pharma-aldenhoven.de

Managing Director
Owner Dr. Rolf Giesen

Management
Mrs Margarete Krupa

Key Account Manager
Mrs Ruth Schumacher
t.b.a.

Purchasing Manager
Mrs Nicole Buhre

Operations Manager
Mr Michael Maisa

Production Manager
Mr Udo Schreiber

Microbiology Manager
Mrs Carolin Sendatzki

Head of Quality Control
Mr Peter Bolduan

Head of Quality Assurance
Mrs Ute Schröder

Quality Management Representative (QMR)
Mrs Victoria Radnai

Career

We are an expanding, medium-sized pharmaceutical company with around 90 employees. We are delighted that you are interested in joining us to enhance our team. We can currently offer you the following vacancies:

> Current vacancies 

If none of the vacancies advertised matches your expectations and qualifications, you can also send us a speculative application. Please send your application – preferably in a PDF file by e-mail – to:
bewerbungen@pharma-aldenhoven.de

Maxim Group

Pharma Aldenhoven GmbH & Co. KG has belonged to the MAXIM Group since 1997. Founded in 1980, the MAXIM Group has evolved in Europe to become a highly efficient and innovative manufacturer of own-brand and retail-brand cosmetic and medicinal products in Europe. It does everything it can to meet the requirements of the industry and also of end consumers to the highest possible standard. As one of the pioneers in the private-label sector, it views the trade brand as a sophisticated brand and transforms functional products into “emotional products”.